UK pharmacies have warned that some patients are using AI-generated photos that make them appear heavier in order to qualify for weight-loss drugs such as Ozempic.
Weight-loss drugs · AI-generated imagery
AI-altered photos are being used to qualify for weight-loss drugs
UK pharmacies have warned that some patients are using AI-generated images that show a higher body weight than they actually have. Because eligibility often depends on body measurements, a misleading image could be used to meet a threshold the patient would not otherwise reach.
How the misuse could work
A simplified sequence of steps described in the warning
STEP 1
Eligibility threshold
Prescribing criteria typically depend on body measurements.
→
STEP 2
Altered image
An AI tool shows the person at a higher weight than their actual one.
→
STEP 3
Pharmacy consultation
Decisions may rely on what is seen or self-reported.
→
STEP 4
Medication supplied
A drug in high demand may reach a patient who does not meet criteria.
What the warning establishes
Some patients are reportedly using AI-generated images of higher weight.
Eligibility for weight-loss medications often depends on body measurements.
Consultations may have limited means of verifying visual or self-reported information.
What remains unclear
How many pharmacies or patients are involved.
Which products are most affected.
Whether any regulator, the NHS, or a manufacturer has responded.
What verification steps pharmacies currently use.
Key takeaway
Verification processes built for medical treatment may not account for AI-generated imagery.
Identity checks
Pressure to strengthen how patient identity is confirmed.
Clinical verification
Measurements and records may need checking beyond images.
Pending guidance
Health authorities and pharmacy bodies may issue advice; none is reported yet.
Continue reading The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in ✓ Signed in — this article isn’t included in your current plan.Unlocking the full article...